You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IDO

Showing 26 - 50 of 220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Zibo (DN1406131, Placebo)

Unknown status
  • Advanced Solid Tumors
  • Zibo, Shandong, China
    PKUCare Luzhong Hospital
Jul 31, 2019

Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder Trial in Spain, United Kingdom,

Recruiting
  • Lung Cancer Non Small Cell
  • +2 more
  • IO102-IO103 in combination with pembrolizumab
  • Duarte, California
  • +18 more
Dec 15, 2022

Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö

Recruiting
  • Latent Tuberculosis
  • +2 more
    • Malmö, Skåne, Sweden
      Skåne University Hospital
    Nov 10, 2022

    Clinical Decision Support System to Reduce Mechanical

    Not yet recruiting
    • Congenital Heart Disease
    • Clinical decision support system (CDSS) for ventilator weaning
    • Boston, Massachusetts
      Boston Children's Hospital
    Jan 19, 2023

    Solid Tumor, Non Small Cell Lung Cancer, Renal Cell Carcinoma Trial in Worldwide (LY3381916, LY3300054)

    Terminated
    • Solid Tumor
    • +3 more
    • Indianapolis, Indiana
    • +11 more
    Jun 8, 2020

    Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)

    Completed
    • Glioblastoma Multiforme
    • +3 more
    • Castro Valley, California
    • +16 more
    May 26, 2020

    Corneal Disease, Corneal Opacity, Corneal Injuries Trial in Worldwide (CorNeat KPro)

    Not yet recruiting
    • Corneal Disease
    • +2 more
    • CorNeat KPro
    • Vancouver, British Columbia, Canada
    • +5 more
    Jan 12, 2023

    Melanoma Trial in United States (IO102/IO103, Nivolumab-Relatlimab)

    Recruiting
    • Melanoma
    • Basking Ridge, New Jersey
    • +6 more
    Jun 23, 2023

    Advanced Solid Tumors Trial in Pittsburgh (Stereotactic Body Radiotherapy (SBRT), navoximod, NLG802 (indoximod Prodrug))

    Not yet recruiting
    • Advanced Solid Tumors
    • Stereotactic Body Radiotherapy (SBRT)
    • +2 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 18, 2022

    Diabetes, Type 2 Trial in Maysan Governorate (drug, combination product, other)

    Completed
    • Diabetes Mellitus, Type 2
    • Metformin 500 mg/day
    • +2 more
    • Maysan Governorate, Iraq
      Maysan Centre for Diabetes and Endocrinology
    Jun 15, 2023

    Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Melanoma
    • FDG PET/CT scan
    • +3 more
    • Chapel Hill, North Carolina
    • +1 more
    Jan 10, 2023

    Predictive Analytics Algorithm to Optimize Weaning of Inotropes

    Recruiting
    • Congenital Heart Disease
    • Clinical Decision support system (CDSS) for inotrope weaning
    • Boston, Massachusetts
      Boston Children's Hospital
    Oct 1, 2021

    Sleep Apnoea Syndrome and Hepatocellular Carcinoma

    Withdrawn
    • Sleep Apnea, Obstructive
    • +2 more
    • Nocturnal oximetry
    • La Tronche, Rhones-Alpes, France
      Minovés-Kotzki
    May 17, 2022

    Advanced Solid Tumors, Lymphoma Trial in Sacramento (epacadostat, SD-101, Radiotherapy)

    Completed
    Has Results
    • Advanced Solid Tumors
    • Lymphoma
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jan 25, 2022

    Corneal Disease, Corneal Opacity, Corneal Injuries Trial in Worldwide (CorNeat KPro)

    Recruiting
    • Corneal Disease
    • +2 more
    • CorNeat KPro
    • Edgewood, Kentucky
    • +7 more
    Apr 24, 2022

    Metastatic Breast Cancer Trial in Poland, United States (Docetaxel, Placebo, Indoximod)

    Completed
    • Metastatic Breast Cancer
    • Gainesville, Florida
    • +39 more
    May 26, 2020

    Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

    Recruiting
    • Metastatic Prostate Cancer
    • +4 more
    • M7824
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Cancer of Ovary, Cancer of the Ovary, Tumors, Ovarian Trial in Pittsburgh (Cisplatin + celecoxib + DC vaccine, Cisplatin + CKM +

    Suspended
    • Cancer of Ovary
    • +5 more
    • Cisplatin + celecoxib + DC vaccine
    • Cisplatin + CKM + Celecoxib + DC Vaccine
    • Pittsburgh, Pennsylvania
    • +1 more
    Dec 15, 2021

    Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Baltimore, Maryland
      The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Jan 3, 2023

    Obstructive Sleep Apnea Syndrome Trial in Paris (Didgeridoo)

    Not yet recruiting
    • Obstructive Sleep Apnea Syndrome
    • Didgeridoo
    • Paris, France
      Hôpital Robert Debré; service de Physiologie
    Jun 17, 2022

    Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic

    Not yet recruiting
    • Tuberculosis
    • 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
    • +5 more
    • Cairo, Kafr El-sheikh, Egypt
    • +1 more
    Oct 11, 2021

    Schizophrenia, Oxidative Stress Trial in Fortaleza (Alpha-lipoic acid, Placebo Oral Tablet)

    Completed
    • Schizophrenia
    • Oxidative Stress
    • Alpha-lipoic acid
    • Placebo Oral Tablet
    • Fortaleza, CE, Brazil
      Núcleo de Pesquisa e Desenvolvimento de Medicamentos - UFC
    Aug 26, 2022

    Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

    Withdrawn
    • Esophageal Squamous Cell Carcinoma
    • +2 more
    • Duarte, California
    • +2 more
    Feb 21, 2022

    Hepatocellular Carcinoma Trial in Shanghai (PD-1 and Lenvatinib Plus TACE)

    Recruiting
    • Hepatocellular Carcinoma
    • PD-1 and Lenvatinib Plus TACE
    • Shanghai, Shanghai, China
      Huashan hospital
    Aug 16, 2022

    Lung Transplant; Complications Trial in Chicago (Etanercept Injection [Enbrel])

    Enrolling by invitation
    • Lung Transplant; Complications
    • Etanercept Injection [Enbrel]
    • Chicago, Illinois
      Northwestern University
    Jul 10, 2023